Please Wait.....
Report
Assisted Reproductive Technology Market Report and Forecast 2025-2034
Market Report I 2025-06-20 I 400 Pages I EMR Inc.
The global assisted reproductive technology market size was valued at USD 23.54 Billion in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 6.50% from 2025 to 2034. Assisted reproductive technology (ART) encompasses medical techniques used to address infertility caused by conditions such as sexually transmitted infections (STIs), endometriosis, polycystic ovary syndrome (PCOS), and primary ovary insufficiency (POI). Infertility affects millions globally, with approximately one in six people of reproductive age experiencing infertility during their lifetime. Increasing awareness and advancements in ART are driving market growth while changing lifestyle patterns and delayed pregnancies contribute to the rising demand for advanced reproductive solutions.
Assisted Reproductive Technology Market Report Overview
The ART market is witnessing rapid technological advancements, including pre-implantation genetic Testing (PGT), which helps identify genetic abnormalities in embryos before implantation. Other innovations, such as endometrial receptivity analysis testing (ERA), evaluate the optimal time for embryo transfer, enhancing the chances of successful pregnancy. Techniques like magnetic activated cell sorting (MACS) are improving sperm selection processes, ensuring better outcomes in fertility clinics. These advancements are enhancing the efficiency and success rates of ART, addressing the increasing burden of infertility.
Assisted reproductive technology involves complex biological processes requiring specialized materials like culture media to support embryo development. Advances in culture media formulations, including the use of granulocyte-macrophage colony-stimulating factor (GM-CSF), are improving embryo viability and implantation success. This growth is crucial for addressing infertility and improving patient outcomes. By optimizing the interaction between the embryo and the endometrium, ART techniques continue to evolve, increasing the likelihood of successful pregnancies and expanding patient treatment options.
The use of donor eggs and donor sperm is increasing as part of comprehensive fertility treatments, particularly for individuals with genetic disorders or diminished reproductive capacity. These treatments offer hope for those unable to conceive naturally and provide alternative solutions for same-sex couples and single parents. With rising demand and ongoing technological innovation, the ART market is poised for significant growth in the coming years.
Assisted Reproductive Technology Market Type Insights
Based on the type, the industry has been segmented into In-vitro fertilization (IVF), artificial insemination, and others. Each segment addresses infertility through advanced medical techniques, offering personalized solutions to patients. Increasing awareness, rising infertility rates, and technological innovations are driving growth across these categories. As reproductive health becomes a priority, these assisted reproductive technologies continue to provide effective and diverse treatment options. In-Vitro Fertilization (IVF) remains the most prevalent ART procedure and is divided into fresh donor, frozen donor, fresh non-donor, and frozen non-donor cycles. Fresh donor IVF uses freshly retrieved donor eggs, while frozen donor cycles involve cryopreserved donor eggs. Fresh non-donor IVF utilizes the patient's own fresh eggs, whereas frozen non-donor cycles use the patient's previously stored eggs. These variations offer flexibility in treatment and are widely used for cases of severe infertility. The increasing success rates of IVF and the ability to preserve reproductive material through cryopreservation contribute to the market's expansion.
Artificial insemination is a less invasive and cost-effective alternative to IVF. It includes four primary methods: intrauterine insemination (IUI), intracervical insemination (ICI), intravaginal insemination (IVI), and intratubal insemination (ITI). IUI is the most common, where sperm is placed directly into the uterus to increase the chances of fertilization. ICI involves placing sperm near the cervix, while IVI delivers sperm into the vagina. ITI, though less frequently used, places sperm in the fallopian tubes for direct fertilization. These methods are particularly effective for treating mild male infertility and unexplained reproductive issues. The others segment includes advanced techniques like gamete intrafallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT). These specialized methods address complex fertility issues, providing alternative solutions when conventional approaches are not suitable. Continued research and innovation in this segment are expected to drive future market growth.
Assisted Reproductive Technology Market End-use Insights
Based on end-uses, the market is categorized into fertility clinics and other facilities and hospitals and other settings. Fertility clinics represent a significant share of the ART market due to their specialized services and advanced technologies. These clinics provide comprehensive fertility solutions, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and egg freezing. The rising prevalence of infertility, coupled with increasing awareness about ART procedures, has led to a growing number of patients seeking treatment in these specialized settings. Additionally, the availability of advanced diagnostic tools and personalized treatment plans in fertility clinics further drives market growth. Other facilities, such as standalone reproductive centers, also play a crucial role in providing accessible and effective ART services.
Hospitals and other settings are also integral to the market, particularly for patients requiring multidisciplinary care and complex reproductive treatments. Hospitals offer a wide range of ART procedures, including fertility preservation for cancer patients, management of high-risk pregnancies, and advanced genetic testing. The presence of highly skilled medical professionals, advanced laboratory infrastructure, and integrated healthcare services make hospitals a preferred choice for many patients. Other settings, such as research institutes and academic medical centers also contribute to market expansion by fostering innovation and offering experimental treatments. The collaboration between hospitals and fertility centers enhances patient access to comprehensive reproductive healthcare solutions, promoting continued growth in the ART market.
Assisted Reproductive Technology Market Regional Insights
The market report spans North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, with each region exhibiting unique growth patterns driven by technological advancements and changing demographics. Europe remains a significant market player, experiencing a surge in IVF and IUI treatment cycles. According to July 2024 data from the ESHRE 40th Annual Meeting in Amsterdam, there has been a 20% increase in ART treatment cycles from 2020 to 2021. This includes 1,103,633 cycles reported by 1,382 clinics across 37 countries. IVF and intracytoplasmic sperm injection (ICSI) treatments accounted for a substantial share, while frozen embryo replacements and preimplantation genetic testing also rose. Clinical pregnancy rates remained stable, with IVF showing 26.3% per aspiration and 33.5% per transfer in 2021, reflecting consistent success rates despite increased treatment volumes. Fertility preservation, including oocyte and tissue banking, is also expanding across the region.
North America is growing rapidly in the assisted reproductive technology market due to advanced healthcare infrastructure, rising infertility rates, and increasing awareness of ART procedures. The United States drives market growth with increased insurance coverage for fertility treatments and the growing acceptance of egg and sperm donation. Technological innovations such as genetic testing and embryo freezing have enhanced success rates, making ART more accessible and effective. The Centers for Disease Control and Prevention (CDC) reports a continuous rise in ART procedures, with IVF cycles being the most common. Canada's ART sector is also expanding, supported by government initiatives to improve fertility services. The region's strong regulatory framework and significant investments in research and development further propel market growth.
Global Assisted Reproductive Technology Market Trends
{{KEY_TRENDS}}
Key Companies & Market Share Insights
The assisted reproductive technology (ART) market is highly competitive, with leading companies focusing on advanced fertility solutions and patient-centric approaches. Some of the companies are:
Cosmos Biomedical Ltd.
Cosmos Biomedical Ltd., established in 2005, is a leading United Kingdom-based supplier of diagnostic products, laboratory equipment, and CPD education. The company supports healthcare and research institutions worldwide.
European Sperm Bank
European Sperm Bank provides comprehensive fertility solutions, specializing in sperm and egg donor matching. They offer personalized consultations, high-quality donor sperm, and extensive support for donor-conceived families.
Bloom IVF Centre
Bloom IVF Centre is a leading provider in the assisted reproductive technology market, offering advanced fertility treatments across various locations in India. The clinic's expertise and comprehensive services have established it as a trusted name in the field, catering to the growing demand for ART procedures.
California Cryobank
California Cryobank is having its headquartered in Los Angeles, CA. It offers assisted reproductive technology (A.R.T.) vials for IVF , GIFT, ZIFT, and ICSI, providing high-quality ICI and IUI sperm preparations to meet diverse patient needs.
Other major players driving innovation and expanding global access include Anecova, CooperSurgical, Merck KGaA, Ferring B.V., FUJIFILM Irvine Scientific, Genea Pty Ltd., Nidacon International AB, Celmatix Inc., Microm U.K. Ltd., Cryolab Ltd., Vitrolife AB and Nikon corporation.
Global Assisted Reproductive Technology Market Report Segmentation
Assisted Reproductive Technology Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments
Type Outlook
In-Vitro Fertilization (IVF)
?? Fresh Donor
?? Frozen Donor
?? Fresh non-Donor
?? Frozen non-Donor
Artificial Insemination
?? Intrauterine Insemination
?? Intracervical Insemination
?? Intravaginal Insemination
?? Intratubal Insemination
Product
Instrument
Accessory & Disposable
Reagent & Media
Age
Women Younger Than Age 35
Women Older Than Age 35
Application
Frozen Embryo Replacement (FER)
Surrogacy
Ovulation Induction
Others
End User
Fertility Clinics & Other Facilities
Hospitals & Others
Region
North America
?? U.S.
?? Canada
Europe
?? U.K.
?? Germany
?? France
?? Italy
?? Spain
Asia Pacific
?? Japan
?? China
?? India
?? Australia
?? South Korea
Latin America
?? Mexico
?? Brazil
?? Argentina
Middle East & Africa (MEA)
?? South Africa
?? Saudi Arabia
?? UAE
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Assisted Reproductive Technology Market Overview
3.1 Global Assisted Reproductive Technology Market Historical Value (2018-2024)
3.2 Global Assisted Reproductive Technology Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Assisted Reproductive Technology Market Landscape*
5.1 Global Assisted Reproductive Technology Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Assisted Reproductive Technology Market: Product Landscape
5.2.1 Analysis by Type
6 Global Assisted Reproductive Technology Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter's Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Assisted Reproductive Technology Market Segmentation (218-2034)
7.1 Global Assisted Reproductive Technology Market (2018-2034) by Type
7.1.1 Market Overview
7.1.2 In-Vitro Fertilization (IVF)
7.1.2.1 Fresh Donor
7.1.2.2 Frozen Donor
7.1.2.3 Fresh Non-Donor
7.1.2.4 Frozen Non-Donor
7.1.3 Artificial Insemination
7.1.3.1 Intrauterine Insemination
7.1.3.2 Intracervical Insemination
7.1.3.3 Intravaginal Insemination
7.1.3.4 Intratubal Insemination
7.2 Global Assisted Reproductive Technology Market (2018-2034) by Product
7.2.1 Market Overview
7.2.2 Instrument
7.2.3 Accessory & Disposable
7.2.4 Reagent & Media
7.3 Global Assisted Reproductive Technology Market (2018-2034) by Age
7.3.1 Market Overview
7.3.2 Women Younger Than Age 35
7.3.3 Women Older Than Age 35
7.4 Global Assisted Reproductive Technology Market (2018-2034) by Application
7.4.1 Market Overview
7.4.2 Frozen Embryo Replacement (FER)
7.4.3 Surrogacy
7.4.4 Ovulation Induction
7.4.5 Others
7.5 Global Assisted Reproductive Technology Market (2018-2034) by End User
7.5.1 Market Overview
7.5.2 Fertility Clinics & Other Facilities
7.5.3 Hospitals & Others
7.6 Global Assisted Reproductive Technology Market (2018-2034) by Region
7.6.1 Market Overview
7.6.2 North America
7.6.3 Europe
7.6.4 Asia Pacific
7.6.5 Latin America
7.6.6 Middle East and Africa
8 North America Assisted Reproductive Technology Market (218-2034)
8.1 North America Assisted Reproductive Technology Market (2018-2034) by Type
8.1.1 Market Overview
8.1.2 In-Vitro Fertilization (IVF)
8.1.2.1 Fresh Donor
8.1.2.2 Frozen Donor
8.1.2.3 Fresh Non-Donor
8.1.2.4 Frozen Non-Donor
8.1.3 Artificial Insemination
8.1.3.1 Intrauterine Insemination
8.1.3.2 Intracervical Insemination
8.1.3.3 Intravaginal Insemination
8.1.3.4 Intratubal Insemination
8.2 North America Assisted Reproductive Technology Market (2018-2034) by Product
8.2.1 Market Overview
8.2.2 Instrument
8.2.3 Accessory & Disposable
8.2.4 Reagent & Media
8.3 North America Assisted Reproductive Technology Market (2018-2034) by Age
8.3.1 Market Overview
8.3.2 Women Younger Than Age 35
8.3.3 Women Older Than Age 35
8.4 North America Assisted Reproductive Technology Market (2018-2034) by Application
8.4.1 Market Overview
8.4.2 Frozen Embryo Replacement (FER)
8.4.3 Surrogacy
8.4.4 Ovulation Induction
8.4.5 Others
8.5 North America Assisted Reproductive Technology Market (2018-2034) by End User
8.5.1 Market Overview
8.5.2 Fertility Clinics & Other Facilities
8.5.3 Hospitals & Others
8.6 North America Assisted Reproductive Technology Market (2018-2034) by Country
8.6.1 United States of America
8.6.1.1 United States of America Assisted Reproductive Technology Market (2018-2034) by Product
8.6.2 Canada
8.6.2.1 Canada Assisted Reproductive Technology Market (2018-2034) by Product
9 Europe Assisted Reproductive Technology Market (218-2034)
9.1 Europe Assisted Reproductive Technology Market (2018-2034) by Type
9.1.1 Market Overview
9.1.2 In-Vitro Fertilization (IVF)
9.1.2.1 Fresh Donor
9.1.2.2 Frozen Donor
9.1.2.3 Fresh Non-Donor
9.1.2.4 Frozen Non-Donor
9.1.3 Artificial Insemination
9.1.3.1 Intrauterine Insemination
9.1.3.2 Intracervical Insemination
9.1.3.3 Intravaginal Insemination
9.1.3.4 Intratubal Insemination
9.2 Europe Assisted Reproductive Technology Market (2018-2034) by Product
9.2.1 Market Overview
9.2.2 Instrument
9.2.3 Accessory & Disposable
9.2.4 Reagent & Media
9.3 Europe Assisted Reproductive Technology Market (2018-2034) by Age
9.3.1 Market Overview
9.3.2 Women Younger Than Age 35
9.3.3 Women Older Than Age 35
9.4 Europe Assisted Reproductive Technology Market (2018-2034) by Application
9.4.1 Market Overview
9.4.2 Frozen Embryo Replacement (FER)
9.4.3 Surrogacy
9.4.4 Ovulation Induction
9.4.5 Others
9.5 Europe Assisted Reproductive Technology Market (2018-2034) by End User
9.5.1 Market Overview
9.5.2 Fertility Clinics & Other Facilities
9.5.3 Hospitals & Others
9.6 Europe Assisted Reproductive Technology Market (2018-2034) by Country
9.6.1 United Kingdom
9.6.1.1 United Kingdom Assisted Reproductive Technology Market (2018-2034) by Product
9.6.2 Germany
9.6.2.1 Germany Assisted Reproductive Technology Market (2018-2034) by Product
9.6.3 France
9.6.3.1 France Assisted Reproductive Technology Market (2018-2034) by Product
9.6.4 Italy
9.6.4.1 Italy Assisted Reproductive Technology Market (2018-2034) by Product
9.6.5 Others
10 Asia Pacific Assisted Reproductive Technology Market (218-2034)
10.1 Asia Pacific Assisted Reproductive Technology Market (2018-2034) by Type
10.1.1 Market Overview
10.1.2 In-Vitro Fertilization (IVF)
10.1.2.1 Fresh Donor
10.1.2.2 Frozen Donor
10.1.2.3 Fresh Non-Donor
10.1.2.4 Frozen Non-Donor
10.1.3 Artificial Insemination
10.1.3.1 Intrauterine Insemination
10.1.3.2 Intracervical Insemination
10.1.3.3 Intravaginal Insemination
10.1.3.4 Intratubal Insemination
10.2 Asia Pacific Assisted Reproductive Technology Market (2018-2034) by Product
10.2.1 Market Overview
10.2.2 Instrument
10.2.3 Accessory & Disposable
10.2.4 Reagent & Media
10.3 Asia Pacific Assisted Reproductive Technology Market (2018-2034) by Age
10.3.1 Market Overview
10.3.2 Women Younger Than Age 35
10.3.3 Women Older Than Age 35
10.4 Asia Pacific Assisted Reproductive Technology Market (2018-2034) by Application
10.4.1 Market Overview
10.4.2 Frozen Embryo Replacement (FER)
10.4.3 Surrogacy
10.4.4 Ovulation Induction
10.4.5 Others
10.5 Asia Pacific Assisted Reproductive Technology Market (2018-2034) by End User
10.5.1 Market Overview
10.5.2 Fertility Clinics & Other Facilities
10.5.3 Hospitals & Others
10.6 Asia Pacific Assisted Reproductive Technology Market (2018-2034) by Country
10.6.1 China
10.6.1.1 China Assisted Reproductive Technology Market (2018-2034) by Product
10.6.2 Japan
10.6.2.1 Japan Assisted Reproductive Technology Market (2018-2034) by Product
10.6.3 India
10.6.3.1 India Assisted Reproductive Technology Market (2018-2034) by Product
10.6.4 ASEAN
10.6.4.1 ASEAN Assisted Reproductive Technology Market (2018-2034) by Product
10.6.5 Australia
10.6.5.1 Australia Assisted Reproductive Technology Market (2018-2034) by Product
10.6.6 Others
11 Latin America Assisted Reproductive Technology Market (218-2034)
11.1 Latin America Assisted Reproductive Technology Market (2018-2034) by Type
11.1.1 Market Overview
11.1.2 In-Vitro Fertilization (IVF)
11.1.2.1 Fresh Donor
11.1.2.2 Frozen Donor
11.1.2.3 Fresh Non-Donor
11.1.2.4 Frozen Non-Donor
11.1.3 Artificial Insemination
11.1.3.1 Intrauterine Insemination
11.1.3.2 Intracervical Insemination
11.1.3.3 Intravaginal Insemination
11.1.3.4 Intratubal Insemination
11.2 Latin America Assisted Reproductive Technology Market (2018-2034) by Product
11.2.1 Market Overview
11.2.2 Instrument
11.2.3 Accessory & Disposable
11.2.4 Reagent & Media
11.3 Latin America Assisted Reproductive Technology Market (2018-2034) by Age
11.3.1 Market Overview
11.3.2 Women Younger Than Age 35
11.3.3 Women Older Than Age 35
11.4 Latin America Assisted Reproductive Technology Market (2018-2034) by Application
11.4.1 Market Overview
11.4.2 Frozen Embryo Replacement (FER)
11.4.3 Surrogacy
11.4.4 Ovulation Induction
11.4.5 Others
11.5 Latin America Assisted Reproductive Technology Market (2018-2034) by End User
11.5.1 Market Overview
11.5.2 Fertility Clinics & Other Facilities
11.5.3 Hospitals & Others
11.6 Latin America Assisted Reproductive Technology Market (2018-2034) by Country
11.6.1 Brazil
11.6.1.1 Brazil Assisted Reproductive Technology Market (2018-2034) by Product
11.6.2 Argentina
11.6.2.1 Argentina Assisted Reproductive Technology Market (2018-2034) by Product
11.6.3 Mexico
11.6.3.1 Mexico Assisted Reproductive Technology Market (2018-2034) by Product
11.6.4 Others
12 Middle East and Africa Assisted Reproductive Technology Market (218-2034)
12.1 Middle East and Africa Assisted Reproductive Technology Market (2018-2034) by Type
12.1.1 Market Overview
12.1.2 In-Vitro Fertilization (IVF)
12.1.2.1 Fresh Donor
12.1.2.2 Frozen Donor
12.1.2.3 Fresh Non-Donor
12.1.2.4 Frozen Non-Donor
12.1.3 Artificial Insemination
12.1.3.1 Intrauterine Insemination
12.1.3.2 Intracervical Insemination
12.1.3.3 Intravaginal Insemination
12.1.3.4 Intratubal Insemination
12.2 Middle East and Africa Assisted Reproductive Technology Market (2018-2034) by Product
12.2.1 Market Overview
12.2.2 Instrument
12.2.3 Accessory & Disposable
12.2.4 Reagent & Media
12.3 Middle East and Africa Assisted Reproductive Technology Market (2018-2034) by Age
12.3.1 Market Overview
12.3.2 Women Younger Than Age 35
12.3.3 Women Older Than Age 35
12.4 Middle East and Africa Assisted Reproductive Technology Market (2018-2034) by Application
12.4.1 Market Overview
12.4.2 Frozen Embryo Replacement (FER)
12.4.3 Surrogacy
12.4.4 Ovulation Induction
12.4.5 Others
12.5 Middle East and Africa Assisted Reproductive Technology Market (2018-2034) by End User
12.5.1 Market Overview
12.5.2 Fertility Clinics & Other Facilities
12.5.3 Hospitals & Others
12.6 Middle East and Africa Assisted Reproductive Technology Market (2018-2034) by Country
12.6.1 Saudi Arabia
12.6.1.1 Saudi Arabia Assisted Reproductive Technology Market (2018-2034) by Product
12.6.2 United Arab Emirates
12.6.2.1 United Arab Emirates Assisted Reproductive Technology Market (2018-2034) by Product
12.6.3 Nigeria
12.6.3.1 Nigeria Assisted Reproductive Technology Market (2018-2034) by Product
12.6.4 South Africa
12.6.4.1 South Africa Assisted Reproductive Technology Market (2018-2034) by Product
12.6.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Initiatives
16.3 Analysis by Joint Ventures
16.4 Analysis by Leading Players
16.5 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia Pacific
17.1.5 Market Share Analysis: Others
17.2 Microm U.K. Ltd.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Company News and Development
17.2.5 Certifications
17.3 CooperSurgical, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Company News and Development
17.3.5 Certifications
17.4 FUJIFILM Irvine Scientific
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Company News and Development
17.4.5 Certifications
17.5 Cyprus IVF Centre
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Company News and Development
17.5.5 Certifications
17.6 Vita Altera IVF Center
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Company News and Development
17.6.5 Certifications
17.7 Cryolab Ltd.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Company News and Development
17.7.5 Certifications
17.8 Vitrolife AB
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Company News and Development
17.8.5 Certifications
17.9 European Sperm Bank
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Company News and Development
17.9.5 Certifications
17.10 Bloom IVF Centre
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Company News and Development
17.10.5 Certifications
17.11 Merck KGaA
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Company News and Development
17.11.5 Certifications
18 Global Assisted Reproductive Technology Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security